Floatz logo

Therapeutic Asset Ratings

395 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bpx-601
Prostate Cancer
Regeneron PharmaceuticalsP1C (36)
Brodalumab
Prostate Cancer
Brian Henick, MDP1C (36)
Cart-Psma Cells
Prostate Cancer
Nova Therapeutics LLCP1C (36)
Cart-Psma-Tgfβrdn Cells
Prostate Cancer
University of PennsylvaniaP1C (36)
Clsp-1025
Prostate Cancer
Clasp Therapeutics, Inc.P1C (36)
Dat-2645
Prostate Cancer
Danatlas Pharmaceuticals Co., LtdP1C (36)
Dntgfβrii-Armoured Steap2-Targeted Autologous Car T-Cell
Prostate Cancer
Shanghai AbelZeta Ltd.P1C (36)
dxc008
Prostate Cancer
Hangzhou DAC Biotechnology Co., Ltd.P1C (36)
dxc014
Prostate Cancer
Hangzhou DAC Biotechnology Co., Ltd.P1C (36)
Ethiodized Oil
Prostate Cancer
University of California, San FranciscoP1C (36)
ETHYLICUM
Prostate Cancer
Icahn School of Medicine at Mount SinaiP1C (36)
exs74539
Prostate Cancer
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1C (36)
flt3 ligand
Prostate Cancer
Ashutosh Kumar TewariP1C (36)
HRS-9815
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.P1C (36)
Ide-161
Prostate Cancer
IDEAYA BiosciencesP1C (36)
Idov-Immune
Prostate Cancer
ViroMissile, Inc.P1C (36)
Ifosfamide
Prostate Cancer
Brigham and Women's HospitalP1C (36)
Janx007
Prostate Cancer
Janux TherapeuticsP1C (36)
Janx014
Prostate Cancer
Janux TherapeuticsP1C (36)
LEVAMLODIPINE
Prostate Cancer
Tyler J CurielP1C (36)
ly4052031
Prostate Cancer
Eli Lilly and CompanyP1C (36)
ly4101174
Prostate Cancer
Eli Lilly and CompanyP1C (36)
Mdpk67B
Prostate Cancer
Med Discovery SAP1C (36)
Micardis®
Prostate Cancer
Tyler J CurielP1C (36)
Moma-313
Prostate Cancer
MOMA TherapeuticsP1C (36)
Showing 301 to 325 of 395 assets
PreviousPage 13 of 16Next